inspection News
Most Popular inspection Story
FDA orders Ranbaxy to reassess operations
Ranbaxy Laboratories has received yet another missive from a displeased FDA. Dated December 21--but not posted at the FDA website until now--the letter chastises Ranbaxy for lackluster efforts to Read more...
Latest Headlines
- August 15, 2011
- June 24, 2011
- March 15, 2011
- February 11, 2011
- November 2, 2010
- September 21, 2010
- July 16, 2010
- May 24, 2010
- February 24, 2010
- February 5, 2010
- February 25, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
